Coriolis Pharma Research GmbH

Coriolis Pharma is a globally operating contract research organization (CRO) and a leader in formulation research and development of biopharmaceutical drugs, including proteins, peptides, monoclonal antibodies, nucleic acids, viral vectors, vaccines and more.

The best solution right from the start combined with speed and flexibility are our key to success. Our collaborative approach to designing customized studies that are aligned with our customers‘ drug development strategy enables us to meet these requirements.

We offer early and late-stage formulation development for liquid and lyophilized drug products, lyophilization process development and analytical method development under R&D and GMP and up to BSL-2. Non-GMP manufacturing services for a wide range of products complete the service portfolio.

More than 750 clients around the globe – from start-ups to big pharma – already rely on our broad know-how. They benefit from our distinguished scientific advisory board that contains some of the most renowned specialists in formulation development. These advisors are actively involved in our customer projects and contribute with independent advice to a successful outcome.

Our services at a glance:

  • Formulation development
  • Analytical method development
  • Comparability studies
  • Lyophilization process development
  • Forced degradation studies
  • In-use stability studies
  • Analytical services up to GMP
  • Non-GMP manufacturing
  • Kategorien
    • Auftragsforschung
  • Gegründet

  • Aktualisiert am